ALDEYRA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.15% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-27
- ALDEYRA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.15%.
- ALDEYRA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2015 was 0.00%, a 100.00% decline from fiscal 2014.
- ALDEYRA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2014 was 15.26%.
- ALDEYRA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2013 was -42.85%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.15% 10-K · filed 2026-02-27 | |
| 2015-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2014-12-31 | 15.26% 10-K · filed 2016-03-30 | -15.26% 10-K · filed 2015-03-23 |
| 2013-12-31 | -42.85% 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |